drugset / Trial / NCT01029470
To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation
Phase 2
Unknown
150 enrolled
Peking University Third Hospital
Chongqing Medical Center for Women and Children · collabPeking Union Medical College Hospital · collabReproductive & Genetic Hospital of CITIC-Xiangya · collabThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Primary objective: To evaluate the efficacy in terms of oocyte retrieval number of rLH supplement in women with hyporesponse to rFSH after pituitary downregulation. Secondary objective: To further explore the efficacy of rLH supplement in women with hyporesponse to rFSH after pituitary downregulation To evaluate the safety of rLH supplementation in hyporesponse women
Timeline
- Start
- 2009-12
- Primary completion
- 2010-10
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Luveris | Protein / enzyme biologic | 75 iu | Subcutaneous |
| Subject | Luveris | Protein / enzyme biologic | 150 iu | Subcutaneous |